Results 161 to 170 of about 32,363 (292)

Insights from electromechanical simulations to assess omecamtiv mecarbil efficacy in heart failure

The Journal of Physiology, EarlyView.
Abstract figure legend Impact of Omecamtiv Mecarbil (OM) on in‐silico models of heart failure. A mathematical electromechanical model of human ventricular tissue is used to simulate the effects of OM in heart failure with reduced ejection fraction (HFrEF).
Maria Teresa Mora, Ilse van Herck, Cécile Daversin‐Catty, Henrik Finsberg, Jordi Llopis‐Lorente, Javier Saiz, Hermenegild Arevalo, Samuel Wall, Beatriz Trenor   +8 more
wiley   +1 more source

NP Lowering in HFrEF

Journal of the American College of Cardiology, 2019
Barry Greenberg, Lori B. Daniels
openaire   +1 more source

Outcomes of Left Bundle Branch Area Pacing in Heart Failure Patients: A Systematic Review

Annals of Noninvasive Electrocardiology, Volume 31, Issue 2, March 2026.
LBBAP demonstrated significant improvements in cardiac function, with most studies reporting substantial increases in LVEF and reductions in QRSd. LBBAP is a promising alternative to conventional pacing strategies, offering superior electrical and mechanical synchronization, enhanced cardiac function, and better clinical outcomes.
Hina Ahmed Siddiqui, Mounika Kotte, Hilana Soliman Omar, Saad Manzoor, Zohaib Qasim, Fnu Abdullah, Sadia Siddique, Muhammad Bari Hassan, Ali Karim, Hansa Devi, Ekta Rani, Aniket Tara, Payal Bai, Sajid Ali, Hina Kumari, Sitara Jabeen, Vikram Kumar, Abida Perveen   +17 more
wiley   +1 more source

Skeletal Muscle Mass Modifies the Prognostic Impact of LDL Cholesterol in Chronic Heart Failure

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Dyslipidaemia is among the major risk factors for atherosclerotic cardiovascular disease. Paradoxically, higher cholesterol levels are associated with better survival in heart failure (HF) of any aetiology. Because cholesterol is an integral component of skeletal muscle structure, one possible explanation involves the interplay ...
Ryosuke Sato, Tania Garfias‐Veitl, Guglielmo Fibbi, Mirela Vatic, Wolfram Doehner, Stefan D. Anker, Stephan von Haehling   +6 more
wiley   +1 more source

APCU 29 Exploring the effects of sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) in elderly patients with heart failure with reduced ejection fraction (HFrEF), with and without type 2 diabetes mellitus (T2DM) [PDF]

I Hazwani, RMR Raja Abdul Wafy, AM Abdul Muizz   +2 more
openalex   +1 more source

Supraventricular Tachycardia Ablation in the Elderly—Characteristics and Outcomes

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
This single‐center retrospective study found that supraventricular tachycardia (SVT) ablation is safe and effective in younger and elderly patients. It should be considered for all symptomatic individuals regardless of age. However, the type of SVT and the presence of comorbidities, including frailty, should be considered in the clinical decision ...
Yi Yi Chua, Julian Cheong Kiat Tay, Eric Tien Siang Lim, Germaine Jie Min Loo, Wei Sheng Jonathan Ong, Xuanming Pung, Daniel Thuan Tee Chong, Kah Leng Ho, Chi Keong Ching   +8 more
wiley   +1 more source

S3 Guideline for the Treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – part 2: Specific clinical and comorbid situations

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 270-282, February 2026.
Summary The present Part 2 of the updated German S3 guideline on the treatment of psoriasis vulgaris provides recommendations for therapy selection in special clinical situations and in the presence of comorbidities. A major focus of this update is the chapter on screening for tuberculosis as well as therapy selection and management in latent ...
Alexander Nast, Andreas Altenburg, Matthias Augustin, Frank Bachmann, Wolf‐Henning Boehncke, Markus Cornberg, Hilte Geerdes‐Fenge, Brit Häcker, Peter Härle, Joachim Klaus, Michaela Köhm, Arno Köllner, Ulrich Mrowietz, Hans‐Michael Ockenfels, Antonia Pennitz, Sandra Philipp, Thomas Richter, Thomas Rosenbach, Tom Schaberg, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Karisa Thölken, Ralph von Kiedrowski, Uwe Willuhn, Christoph Zeyen   +25 more
wiley   +1 more source

S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Hilfestellungen für besondere klinische Situationen und bei Vorliegen von Komorbiditäten

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 270-284, February 2026.
Zusammenfassung Der vorliegende Teil 2 der aktualisierten S3‐Leitlinie zur Therapie der Psoriasis vulgaris bietet Empfehlungen zur Therapieauswahl in besonderen klinischen Situationen sowie bei Vorliegen von Komorbidität. Ein Schwerpunkt des Updates liegt im Kapitel Screening auf Tuberkulose sowie in der Therapieauswahl und im Management bei latenter ...
Alexander Nast, Andreas Altenburg, Matthias Augustin, Frank Bachmann, Wolf‐Henning Boehncke, Markus Cornberg, Hilte Geerdes‐Fenge, Brit Häcker, Peter Härle, Joachim Klaus, Michaela Köhm, Arno Köllner, Ulrich Mrowietz, Hans‐Michael Ockenfels, Antonia Pennitz, Sandra Philipp, Thomas Richter, Thomas Rosenbach, Tom Schaberg, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Karisa Thölken, Ralph von Kiedrowski, Uwe Willuhn, Christoph Zeyen   +25 more
wiley   +1 more source

Benefits of renal denervation in HFrEF [PDF]

Nature Reviews Cardiology, 2018
openaire   +2 more sources

Safety and efficacy of renal denervation in patients with heart failure with reduced ejection fraction (HFrEF): A systematic review and meta-analysis [PDF]

, 2022
Zhiqiu Xia, Li Han, Peter Ricci Pellegrino, Alicia M. Schiller, Logan D. Harrold, Robert L. Lobato, Steven J. Lisco, Irving H. Zucker, Hanjun Wang   +8 more
openalex   +1 more source